Close Menu

Insider Lessons

Prof-Like Substance shares what he's learned since becoming an associate journal editor two months ago. "Like it or not, we are the vehicle that drives the speed of publication," Prof-Like says, as he lays out his experience so far. He says that when it comes to papers that are "seemingly similar in content and quality," it's typically easier for journal editors to find reviewers for those manuscripts that list prominent authors than those that do not.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.